Education
About Us
Working with TipRanks
Follow Us
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
Total Valuation
Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $3.24M. The enterprise value is $735.65K.
Market Cap$3.24M
Enterprise Value$735.65K
Share Statistics
Shuttle Pharmaceuticals Holdings, Inc. has 1,603,285 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,603,285
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -12.90 and return on invested capital (ROIC) is -403.38%.
Return on Equity (ROE)-12.90
Return on Assets (ROA)-3.65
Return on Invested Capital (ROIC)-403.38%
Return on Capital Employed (ROCE)-7.91
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is ―. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is -0.00011.
PE Ratio―
PS Ratio0.00
PB Ratio312.73
Price to Fair Value312.73
Price to FCF-30.27
Price to Operating Cash Flow-0.40
PEG Ratio-0.00011
Income Statement
In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -9.14M in profits. Earnings per share was -885.73.
Revenue0.00
Gross Profit0.00
Operating Income-7.70M
Pretax Income-9.14M
Net Income-9.14M
EBITDA-7.78M
Earnings Per Share (EPS)-885.73
Cash Flow
In the last 12 months, operating cash flow was -11.20M and capital expenditures 6.00, giving a free cash flow of -11.20M billion.
Operating Cash Flow-11.20M
Free Cash Flow-11.20M
Free Cash Flow per Share-6.98
Dividends & Yields
Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-88.78%
50-Day Moving Average1.79
200-Day Moving Average3.57
Relative Strength Index (RSI)51.35
Average Volume (3m)424.69K
Important Dates
Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 1.44, with Debt / Equity ratio of 47.87%
Current Ratio1.44
Quick Ratio1.44
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio-5.66
Taxes
In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is -28.41, with an EV/FCF ratio of -30.16.
EV to Sales0.00
EV to EBITDA-28.41
EV to Free Cash Flow-30.16
EV to Operating Cash Flow-30.16
Balance Sheet
Shuttle Pharmaceuticals Holdings, Inc. has $2.09M in cash and marketable securities with $667.33K in debt, giving a net cash position of $1.43M billion.
Cash & Marketable Securities$2.09M
Total Debt$667.33K
Net Cash$1.43M
Net Cash Per Share$0.89
Tangible Book Value Per Share$0.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast79.31%